Morning Overview on MSN
The FDA approved a Pfizer RSV vaccine for at-risk adults as young as 18
Adults between 18 and 59 who face elevated risk of severe respiratory syncytial virus infection now have a licensed vaccine ...
The agreement finally brings to an end years of boardroom infighting, legal battles and an increasingly fractured commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results